CHINOOK THERAPEUTICS, INC. Quarterly Current Ratio in % from Q3 2015 to Q2 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Chinook Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q2 2023.
  • Chinook Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2023 was 719 %, a 18.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 719 -163 -18.5% Jun 30, 2023
Q1 2023 851 +63.3 +8.04% Mar 31, 2023
Q4 2022 881 +66 +8.1% Dec 31, 2022
Q3 2022 888 -26.6 -2.91% Sep 30, 2022
Q2 2022 882 -102 -10.4% Jun 30, 2022
Q1 2022 787 -211 -21.2% Mar 31, 2022
Q4 2021 815 -188 -18.7% Dec 31, 2021
Q3 2021 914 -27.5 -2.92% Sep 30, 2021
Q2 2021 984 +167 +20.4% Jun 30, 2021
Q1 2021 999 +189 +23.3% Mar 31, 2021
Q4 2020 1K +186 +22.8% Dec 31, 2020
Q3 2020 942 +92 +10.8% Sep 30, 2020
Q2 2020 818 -86.1 -9.53% Jun 30, 2020
Q1 2020 810 -81.5 -9.14% Mar 31, 2020
Q4 2019 817 -75.4 -8.46% Dec 31, 2019
Q3 2019 850 -21.8 -2.5% Sep 30, 2019
Q2 2019 904 +1.1 +0.12% Jun 30, 2019
Q1 2019 891 -123 -12.2% Mar 31, 2019
Q4 2018 892 -202 -18.5% Dec 31, 2018
Q3 2018 872 -323 -27% Sep 30, 2018
Q2 2018 903 -306 -25.3% Jun 30, 2018
Q1 2018 1.01K -111 -9.87% Mar 31, 2018
Q4 2017 1.09K +27.4 +2.57% Dec 31, 2017
Q3 2017 1.19K +82.8 +7.44% Sep 30, 2017
Q2 2017 1.21K +38.5 +3.29% Jun 30, 2017
Q1 2017 1.13K -158 -12.3% Mar 31, 2017
Q4 2016 1.07K -17.8 -1.64% Dec 31, 2016
Q3 2016 1.11K +322 +40.7% Sep 30, 2016
Q2 2016 1.17K Jun 30, 2016
Q1 2016 1.28K Mar 31, 2016
Q4 2015 1.08K Dec 31, 2015
Q3 2015 790 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.